Stability Studies of Rooperol and Analogues by In Vitro Metabolism With HPLC/MS Detection

dc.contributor.advisorKerwin, Sean M.
dc.contributor.authorBohanon, Amanda
dc.contributor.committeeMemberDavid, Wendi
dc.contributor.committeeMemberDu, Liqin
dc.date.accessioned2019-05-08T15:53:16Z
dc.date.available2019-05-08T15:53:16Z
dc.date.issued2019-05
dc.description.abstractAfrican Potato, Hypoxis hemerocallidea, has a long history of use by the indigenous people of South Africa to treat cancer and a variety of other diseases. Extracts from the corm contain the norligan bisglycoside hypoxoside, which is hydrolyzed in the body to yield the anticancer agent rooperol (1,5-bis(3’,4’-dihydroxyphenyl)pent-1-en-4- yne). Studies have shown that rooperol selectively inhibits the growth of several cancer cell lines. Phase I clinical trials of rooperol in lung cancer patients suggested promising activity with no dose-limiting toxicity. However, rooperol is rapidly converted to biologically inactive sulfate and glucuronide metabolites. Thus, a relatively small amount of the drug reaches the tumor site. Bioisosteric analogues of rooperol have been synthesized with the aim of increasing metabolic stability while preserving the anticancer properties of the parent drug. The goal of this research is to investigate the metabolic stability of rooperol and analogues. As part of this study, we employ an in vitro metabolism assay with porcine liver microsomes. Microsomes are supplemented with the cofactor UDP-glucuronic acid and the pore-forming peptide alamethicin. The suitability of this assay to characterize the Phase II metabolism of phenolic compounds was established with the plant phytochemical 3-hydroxytyrosol. The time-dependent metabolism of this compound was determined by HPLC assay, and the formation of the glucuronide Phase II metabolite was confirmed by HPLC/MS. The time course for disappearance of 3-hydroxytyrosol followed first-order kinetics with an apparent half-life of around 61 minutes. We have recently employed this assay to quantify the metabolic lability of rooperol. The disappearance of rooperol monitored by HPLC revealed an exceptionally short half-life of about 3 minutes. The identities of monoglucuronide and diglucuronide metabolites of rooperol were verified by HPLC/MS. The extreme metabolic lability of rooperol demonstrates the need to identify more metabolically stable analogues. We will discuss the integration of this in vitro metabolism assay in a work- flow designed to identify rooperol analogues exhibiting increased metabolic stability while retaining the cytotoxic activity of rooperol.
dc.description.departmentChemistry and Biochemistry
dc.formatText
dc.format.extent102 pages
dc.format.medium1 file (.pdf)
dc.identifier.citationBohanon, A. (2019). <i>Stability studies of rooperol and analogues by in vitro metabolism with HPLC/MS detection</i> (Unpublished thesis). Texas State University, San Marcos, Texas.
dc.identifier.urihttps://hdl.handle.net/10877/8179
dc.language.isoen
dc.subjectRooperol
dc.subjectHydroxytyrosol
dc.subjectGlucuronidation
dc.subjectIn vitro
dc.subjectMetabolism
dc.subjectHPLC/MS
dc.subject.lcshHigh performance liquid chromatography
dc.subject.lcshCancer--Treatment--Research
dc.titleStability Studies of Rooperol and Analogues by In Vitro Metabolism With HPLC/MS Detection
dc.typeThesis
thesis.degree.departmentChemistry and Biochemistry
thesis.degree.disciplineBiochemistry
thesis.degree.grantorTexas State University
thesis.degree.levelMasters
thesis.degree.nameMaster of Science

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
BOHANON-THESIS-2019.pdf
Size:
1.85 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
LICENSE.txt
Size:
2.12 KB
Format:
Plain Text
Description: